APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duck Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Duck Medicine and Vaccines Market Outlook and Growth Opportunities 2026

30 December 2025198 pages

Choose your research edition.

Industry ResearchDuck Medicine and Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Duck Medicine and Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Duck Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duck Medicine and Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Duck Medicine and Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Duck Medicine and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Duck Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Duck Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Duck Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Duck Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Duck Medicine and Vaccines market include Zoetis, Yebio, Vaksindo, Ringpu Biology, QYH Biotech, Merial, Merck Animal Health, Harbin Veterinary Research Institute and FATRO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Duck Medicine and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Duck Medicine and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Duck Medicine and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Duck Medicine and Vaccines market.

Duck Medicine and Vaccines Segment by Company

Zoetis

Yebio

Vaksindo

Ringpu Biology

QYH Biotech

Merial

Merck Animal Health

Harbin Veterinary Research Institute

FATRO

Elanco (Lohmann)

DHN

ChengDu Tecbond

CEVA

CAVAC

Duck Medicine and Vaccines Segment by Type

Medicine

Vaccines

Duck Medicine and Vaccines Segment by Application

Farm

Government

Duck Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Duck Medicine and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Duck Medicine and Vaccines key companies, revenue, market share, and recent developments.

3. To split the Duck Medicine and Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Duck Medicine and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Duck Medicine and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Duck Medicine and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duck Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Duck Medicine and Vaccines industry.

Chapter 3: Detailed analysis of Duck Medicine and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Duck Medicine and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Duck Medicine and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Duck Medicine and Vaccines Industry Trends Table 2. Duck Medicine and Vaccines Industry Drivers Table 3. Duck Medicine and Vaccines Industry Opportunities and Challenges Table 4. Duck Medicine and Vaccines Industry Restraints Table 5. Global Duck Medicine and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Duck Medicine and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Duck Medicine and Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Duck Medicine and Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Duck Medicine and Vaccines Company, Product Type & Application Table 10. Global Duck Medicine and Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Duck Medicine and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicine Table 15. Significant Companies of Vaccines Table 16. Global Duck Medicine and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Duck Medicine and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Duck Medicine and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Duck Medicine and Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Duck Medicine and Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Farm Table 22. Significant Companies of Government Table 23. Global Duck Medicine and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Duck Medicine and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Duck Medicine and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Duck Medicine and Vaccines Sales Value Share by Application (2021-2026) Table 27. Global Duck Medicine and Vaccines Sales Value Share by Application (2027-2032) Table 28. Global Duck Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Duck Medicine and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Duck Medicine and Vaccines Sales Value Share by Region (2021-2026) Table 31. Global Duck Medicine and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Duck Medicine and Vaccines Sales Value Share by Region (2027-2032) Table 33. Global Duck Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Duck Medicine and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Duck Medicine and Vaccines Sales Value Market Share by Country (2021-2026) Table 36. Global Duck Medicine and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Duck Medicine and Vaccines Sales Value Market Share by Country (2027-2032) Table 38. Zoetis Company Information Table 39. Zoetis Business Overview Table 40. Zoetis Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Zoetis Duck Medicine and Vaccines Product Portfolio Table 42. Zoetis Recent Development Table 43. Yebio Company Information Table 44. Yebio Business Overview Table 45. Yebio Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Yebio Duck Medicine and Vaccines Product Portfolio Table 47. Yebio Recent Development Table 48. Vaksindo Company Information Table 49. Vaksindo Business Overview Table 50. Vaksindo Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Vaksindo Duck Medicine and Vaccines Product Portfolio Table 52. Vaksindo Recent Development Table 53. Ringpu Biology Company Information Table 54. Ringpu Biology Business Overview Table 55. Ringpu Biology Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Ringpu Biology Duck Medicine and Vaccines Product Portfolio Table 57. Ringpu Biology Recent Development Table 58. QYH Biotech Company Information Table 59. QYH Biotech Business Overview Table 60. QYH Biotech Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. QYH Biotech Duck Medicine and Vaccines Product Portfolio Table 62. QYH Biotech Recent Development Table 63. Merial Company Information Table 64. Merial Business Overview Table 65. Merial Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merial Duck Medicine and Vaccines Product Portfolio Table 67. Merial Recent Development Table 68. Merck Animal Health Company Information Table 69. Merck Animal Health Business Overview Table 70. Merck Animal Health Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Animal Health Duck Medicine and Vaccines Product Portfolio Table 72. Merck Animal Health Recent Development Table 73. Harbin Veterinary Research Institute Company Information Table 74. Harbin Veterinary Research Institute Business Overview Table 75. Harbin Veterinary Research Institute Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Harbin Veterinary Research Institute Duck Medicine and Vaccines Product Portfolio Table 77. Harbin Veterinary Research Institute Recent Development Table 78. FATRO Company Information Table 79. FATRO Business Overview Table 80. FATRO Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. FATRO Duck Medicine and Vaccines Product Portfolio Table 82. FATRO Recent Development Table 83. Elanco (Lohmann) Company Information Table 84. Elanco (Lohmann) Business Overview Table 85. Elanco (Lohmann) Duck Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Elanco (Lohmann) Duck Medicine and Vaccines Product Portfolio Table 87. Elanco (Lohmann) Recent Development Table 88. DHN Company Information Table 89. DHN Business Overview Table 90. DHN Duck Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. DHN Duck Medicine and Vaccines Product Portfolio Table 92. DHN Recent Development Table 93. ChengDu Tecbond Company Information Table 94. ChengDu Tecbond Business Overview Table 95. ChengDu Tecbond Duck Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. ChengDu Tecbond Duck Medicine and Vaccines Product Portfolio Table 97. ChengDu Tecbond Recent Development Table 98. CEVA Company Information Table 99. CEVA Business Overview Table 100. CEVA Duck Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CEVA Duck Medicine and Vaccines Product Portfolio Table 102. CEVA Recent Development Table 103. CAVAC Company Information Table 104. CAVAC Business Overview Table 105. CAVAC Duck Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CAVAC Duck Medicine and Vaccines Product Portfolio Table 107. CAVAC Recent Development Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Duck Medicine and Vaccines Product Image Figure 2. Global Duck Medicine and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duck Medicine and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Duck Medicine and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicine Image Figure 8. Vaccines Image Figure 9. Global Duck Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Duck Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Duck Medicine and Vaccines Sales Value Share by Type (2021-2032) Figure 12. Farm Image Figure 13. Government Image Figure 14. Global Duck Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Duck Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Duck Medicine and Vaccines Sales Value Share by Application (2021-2032) Figure 17. Global Duck Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Duck Medicine and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Duck Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 20. North America Duck Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Duck Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Duck Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Duck Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Duck Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Duck Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. South America Duck Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Duck Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Duck Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Farm
  • Government
Companies covered
  • Zoetis
  • Yebio
  • Vaksindo
  • Ringpu Biology
  • QYH Biotech
  • Merial
  • Merck Animal Health
  • Harbin Veterinary Research Institute
  • FATRO
  • Elanco (Lohmann)
  • DHN
  • ChengDu Tecbond
  • CEVA
  • CAVAC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Duck Medicine and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Duck Medicine and Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Duck Medicine and Vaccines Market Dynamics
  1. 2.1 Duck Medicine and Vaccines Industry Trends
  2. 2.2 Duck Medicine and Vaccines Industry Drivers
  3. 2.3 Duck Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Duck Medicine and Vaccines Industry Restraints
3 Duck Medicine and Vaccines Market by Company
  1. 3.1 Global Duck Medicine and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Duck Medicine and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Duck Medicine and Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Duck Medicine and Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Duck Medicine and Vaccines Company Product Type and Application
  6. 3.6 Global Duck Medicine and Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Duck Medicine and Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Duck Medicine and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Duck Medicine and Vaccines Market by Type
  1. 4.1 Duck Medicine and Vaccines Type Introduction
  2. 4.1.1 Medicine
  3. 4.1.2 Vaccines
  4. 4.2 Global Duck Medicine and Vaccines Sales Value by Type
  5. 4.2.1 Global Duck Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Duck Medicine and Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Duck Medicine and Vaccines Sales Value Share by Type (2021-2032)
5 Duck Medicine and Vaccines Market by Application
  1. 5.1 Duck Medicine and Vaccines Application Introduction
  2. 5.1.1 Farm
  3. 5.1.2 Government
  4. 5.2 Global Duck Medicine and Vaccines Sales Value by Application
  5. 5.2.1 Global Duck Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Duck Medicine and Vaccines Sales Value by Application (2021-2032)
  7. 5.2.3 Global Duck Medicine and Vaccines Sales Value Share by Application (2021-2032)
6 Duck Medicine and Vaccines Regional Value Analysis
  1. 6.1 Global Duck Medicine and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Duck Medicine and Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Duck Medicine and Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Duck Medicine and Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Duck Medicine and Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Duck Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Duck Medicine and Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Duck Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Duck Medicine and Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Duck Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Duck Medicine and Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Duck Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Duck Medicine and Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Duck Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Duck Medicine and Vaccines Country-level Value Analysis
  1. 7.1 Global Duck Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Duck Medicine and Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Duck Medicine and Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Duck Medicine and Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Duck Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Duck Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Duck Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Duck Medicine and Vaccines Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Yebio
  8. 8.2.1 Yebio Company Information
  9. 8.2.2 Yebio Business Overview
  10. 8.2.3 Yebio Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yebio Duck Medicine and Vaccines Product Portfolio
  12. 8.2.5 Yebio Recent Developments
  13. 8.3 Vaksindo
  14. 8.3.1 Vaksindo Company Information
  15. 8.3.2 Vaksindo Business Overview
  16. 8.3.3 Vaksindo Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vaksindo Duck Medicine and Vaccines Product Portfolio
  18. 8.3.5 Vaksindo Recent Developments
  19. 8.4 Ringpu Biology
  20. 8.4.1 Ringpu Biology Company Information
  21. 8.4.2 Ringpu Biology Business Overview
  22. 8.4.3 Ringpu Biology Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ringpu Biology Duck Medicine and Vaccines Product Portfolio
  24. 8.4.5 Ringpu Biology Recent Developments
  25. 8.5 QYH Biotech
  26. 8.5.1 QYH Biotech Company Information
  27. 8.5.2 QYH Biotech Business Overview
  28. 8.5.3 QYH Biotech Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 QYH Biotech Duck Medicine and Vaccines Product Portfolio
  30. 8.5.5 QYH Biotech Recent Developments
  31. 8.6 Merial
  32. 8.6.1 Merial Company Information
  33. 8.6.2 Merial Business Overview
  34. 8.6.3 Merial Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merial Duck Medicine and Vaccines Product Portfolio
  36. 8.6.5 Merial Recent Developments
  37. 8.7 Merck Animal Health
  38. 8.7.1 Merck Animal Health Company Information
  39. 8.7.2 Merck Animal Health Business Overview
  40. 8.7.3 Merck Animal Health Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Animal Health Duck Medicine and Vaccines Product Portfolio
  42. 8.7.5 Merck Animal Health Recent Developments
  43. 8.8 Harbin Veterinary Research Institute
  44. 8.8.1 Harbin Veterinary Research Institute Company Information
  45. 8.8.2 Harbin Veterinary Research Institute Business Overview
  46. 8.8.3 Harbin Veterinary Research Institute Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Veterinary Research Institute Duck Medicine and Vaccines Product Portfolio
  48. 8.8.5 Harbin Veterinary Research Institute Recent Developments
  49. 8.9 FATRO
  50. 8.9.1 FATRO Company Information
  51. 8.9.2 FATRO Business Overview
  52. 8.9.3 FATRO Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FATRO Duck Medicine and Vaccines Product Portfolio
  54. 8.9.5 FATRO Recent Developments
  55. 8.10 Elanco (Lohmann)
  56. 8.10.1 Elanco (Lohmann) Company Information
  57. 8.10.2 Elanco (Lohmann) Business Overview
  58. 8.10.3 Elanco (Lohmann) Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Elanco (Lohmann) Duck Medicine and Vaccines Product Portfolio
  60. 8.10.5 Elanco (Lohmann) Recent Developments
  61. 8.11 DHN
  62. 8.11.1 DHN Company Information
  63. 8.11.2 DHN Business Overview
  64. 8.11.3 DHN Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DHN Duck Medicine and Vaccines Product Portfolio
  66. 8.11.5 DHN Recent Developments
  67. 8.12 ChengDu Tecbond
  68. 8.12.1 ChengDu Tecbond Company Information
  69. 8.12.2 ChengDu Tecbond Business Overview
  70. 8.12.3 ChengDu Tecbond Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ChengDu Tecbond Duck Medicine and Vaccines Product Portfolio
  72. 8.12.5 ChengDu Tecbond Recent Developments
  73. 8.13 CEVA
  74. 8.13.1 CEVA Company Information
  75. 8.13.2 CEVA Business Overview
  76. 8.13.3 CEVA Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CEVA Duck Medicine and Vaccines Product Portfolio
  78. 8.13.5 CEVA Recent Developments
  79. 8.14 CAVAC
  80. 8.14.1 CAVAC Company Information
  81. 8.14.2 CAVAC Business Overview
  82. 8.14.3 CAVAC Duck Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CAVAC Duck Medicine and Vaccines Product Portfolio
  84. 8.14.5 CAVAC Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst